Cellectis (CLLS) Change in Accured Expenses (2021 - 2022)
Cellectis' (CLLS) quarterly Change in Accured Expenses came in at $37000.0 in Q1 2022, down 77.84% year-on-year from $167000.0 in Q1 2021, and down 77.84% quarter-over-quarter from $167000.0 in Q1 2021.
Cellectis (CLLS) Change in Accured Expenses (2021 - 2022) Analysis & Trends
Cellectis' Change in Accured Expenses history runs 2 years deep, the most recent figure standing at $37000.0 for Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -16.82 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -16.74 Mn |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 37,000.00 |
| Mar 31, 2022 | 37,000.00 |
| Mar 31, 2021 | 167,000.00 |
| Mar 31, 2021 | 167,000.00 |